What is Lifesci Capital’s Forecast for Immunome Q1 Earnings?

Immunome, Inc. (NASDAQ:IMNM – Free Report) – Stock analysts at Lifesci Capital raised their Q1 2026 earnings per share (EPS) estimates for Immunome in a research report issued to clients and investors on Wednesday, August 6th. Lifesci Capital analyst C. Zhu now expects that the company will post earnings per share of ($0.73) for the […]

Leave a Reply

Your email address will not be published.

Previous post Q1 Earnings Forecast for Cronos Group Issued By Roth Capital
Next post Poll: With Tom Brady now immortalized, what’s the best statue in Boston?